TTOO News and Press, T2 Biosystems Inc. From 12/20/23

2023-12-20 10:00:08 ET More on Health Care Select Sector SPDR XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble For further details see: ...

2023-12-20 08:14:03 ET Polished ( POL ) +108% . Applied UV  ( AUVI ) +30% . Longeveron  ( LGVN ) +31% Announces Additional Positive Clinical Data and Imaging Biomarker Results from the CLEAR MIND Phase 2a Trial of Lomecel- in the Treatment of Mild A...

2023-11-13 09:35:44 ET T2 Biosystems (NASDAQ: TTOO) stock price has collapsed to a record low as concerns about the company’s future continued. Shares of the popular penny stock have collapsed to a split-adjusted low of $4.72, meaning they have plunged by over 92% this year. They...

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

T2 Biosystems Inc. (TTOO) is expected to report for Q1 2024

2023-11-01 13:02:53 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips T2 Biosystems (NASDAQ: TTOO ) stock is in the green after the medical diagnostics company announced that it had received written notice from the Nasdaq Listing Qualifications St...

2023-11-01 09:17:15 ET More on T2 Biosystems T2 Biosystems announces amendment, extension of CRG term loan agreement T2 Biosystems falls 11% in wake of reverse stock split, preliminary earnings Seeking Alpha’s Quant Rating on T2 Biosystems For further ...

LEXINGTON, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that on October 31, 2023 it received written notice from the Nasdaq Lis...

LEXINGTON, Mass., Oct. 24, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today highlighted four new studies supporting the T2Bacteria ® Panel, the T2Candida ® Panel an...

2023-10-23 13:05:01 ET More on T2 Biosystems T2 Biosystems, Inc. (TTOO) Preliminary Q3 2023 Earnings Call Transcript T2 Biosystems, Inc. (TTOO) Q2 2023 Earnings Call Transcript T2 Biosystems falls 11% in wake of reverse stock split, preliminary earnings T2 Bi...